Search Results

The vacated space of volume/price of the drugs centralized procurement with quantity in secondary and above public hospitals of China.

• Authors : Wang, Jingliang¹ (AUTHOR); Zhang, Siyu^1,2 (AUTHOR); Wang, Canghong³ (AUTHOR)

• Source: BMC Health Services Research. 6/29/2024, Vol. 24 Issue 1, p1-17. 17p.

Record details

Comparison of the effectiveness, safety, and costs of anti‐Parkinson drugs: A multiple‐center retrospective study.

• Authors : Li, Wenting^1,2 (AUTHOR); Zhang, Hua³ (AUTHOR); Zhang, Yuan⁴ (AUTHOR)

• Source: CNS Neuroscience & Therapeutics. Apr2024, Vol. 30 Issue 4, p1-12. 12p.

Record details

Short-term differences in drug prices after implementation of the national essential medicines system: A case study in rural Jiangxi Province, China.

• Authors : Junyong Wang^1,2; Xia Liu²; Suzhen Wang²

• Source: Indian Journal of Pharmacology. Sep/Oct2015, Vol. 47 Issue 5, p535-539. 5p.

Record details

Price negotiation and pricing of anticancer drugs in China: An observational study.

• Authors : Zhou, Jing^1,2 (AUTHOR); Lan, Tianjiao^1,2 (AUTHOR); Lu, Hao³ (AUTHOR)

• Source: PLoS Medicine. 1/2/2024, Vol. 21 Issue 1, p1-18. 18p.

Record details

Direct economic burden of patients with tuberculous meningitis in western China.

• Authors : Ma, Xue‐Ping¹ (AUTHOR); Li, Jin‐Mei² (AUTHOR); Zhou, Dong² (AUTHOR)

• Source: Acta Neurologica Scandinavica. Nov2021, Vol. 144 Issue 5, p535-545. 11p.

Record details

The effects of pricing policy on the prices and supply of low-cost medicines in Shandong, China: evidence from an interrupted time series analysis.

• Authors : Rong, Xuejing^1,2; Yin, Jia^1,2; Duan, Shuoyun^1,2

• Source: BMC Public Health. 4/29/2020, Vol. 20 Issue 1, p1-10. 10p. 3 Charts, 4 Graphs.

Record details

Progress on drug pricing negotiations in China.

• Authors : Mi Tang¹; Peipei Song²; Jiangjiang He^1,3

• Source: BioScience Trends. Dec2019, Vol. 13 Issue 6, p464-468. 5p.

Record details

Cost‐effectiveness analysis of cabozantinib as second‐line therapy in advanced hepatocellular carcinoma.

• Authors : Liao, Weiting^1,2 (AUTHOR); Huang, Jiaxing^1,2 (AUTHOR); Hutton, David³ (AUTHOR)

• Source: Liver International. Dec2019, Vol. 39 Issue 12, p2408-2416. 9p. 1 Diagram, 2 Charts, 3 Graphs.

Record details

The usage and costs of national drug price-negotiated anticancer medicines in a first-tier city in Northeast China: a study based on health insurance data.

• Authors : Li, Bao-Xin; Wang, Ya-Qun; Yi, Yuan-Yuan

Subjects: HEALTH insurance; BUSINESS negotiation; DRUG accessibilityCHINA

• Source: BMC Public Health; 5/14/2024, Vol. 24, p1-12, 12p

Record details

Drug Prices Lowered by 52 Percent on Average after Reform.

• Source: China Today. Jun2019, Vol. 68 Issue 6, p8-8. 1/4p.

Record details